Robert E. Baldini

Robert E. Baldini has filed trades across 2 companies (mainly through SEC (Form 4)), most often in KOS Pharmaceuticals Inc and KV Pharmaceutical Co /DE/. We count 14 filings; the first trade dates from 26 January 2006 and the latest from 5 August 2010.

Sales make up the whole of the open-market record (6 sales, €982k). Other entries cover 2 share grants and 5 option exercises.

The newest entry dates from 12 August 2010: a share grant, in KV Pharmaceutical Co /DE/. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.